Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26020344 | 0.98 | CYP11B1 (0.34) | CYP11B1APP | |
| SCHEMBL26020356 | 0.97 | CYP11B1 (0.33) | CYP11B1PIM3APP | |
| SCHEMBL26020926 | 0.94 | CYP11B1 (0.33) | CYP11B1APP | |
| SCHEMBL26021004 | 0.93 | S1PR4 (0.31) | CYP11B1 | |
| SCHEMBL26021033 | 0.93 | ALDH1A1 (0.33) | — | |
| SCHEMBL26020343 | 0.92 | CYP11B1 (0.36) | CYP11B1PIM3 | |
| SCHEMBL26020353 | 0.92 | CYP11B1 (0.36) | CYP11B1PIM3 | |
| SCHEMBL26020351 | 0.91 | CYP11B1 (0.34) | CYP11B1 | |
| SCHEMBL26020315 | 0.91 | CYP11B1 (0.34) | CYP11B1APP | |
| SCHEMBL23626438 | 0.91 | CYP11B1 (0.35) | CYP11B1PIM3APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, NR1D1 | CYP11B1 469/4885PIM3 4086/4885APP 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.